Palvella Therapeutics PVLA
NASDAQ PVLA
$132.47 -0.26 (-0.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Palvella Therapeutics (PVLA) reported Return on Capital Employed [ROCE] of -23.41% for Q2 2026, up 16.23 percentage points from -39.64% a year earlier and up 6.48 percentage points from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Palvella Therapeutics posted Return on Capital Employed [ROCE] of -61.71%, down 22.40 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of -28.10 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -39.31% in FY2024 (-15.17 pp), -24.14% in FY2023 (+25.29 pp), -49.43% in FY2022 (+16.40 pp) and -65.84% in FY2021 (-32.22 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • Year over year, Return on Capital Employed [ROCE] gained in three of the last eight quarters, with an average year-over-year change of -7.77 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2024 (a gain of 129.15 percentage points); the low point was Q3 2025 (a drop of 72.48 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -29.88% (Q1 2026), -74.37% (Q4 2025) and -52.75% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Palvella Therapeutics 1.91 Bn 1.66 Bn - -23.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.41%
Mar 31, 2026 -29.88%
Dec 31, 2025 -74.37%
Sep 30, 2025 -52.75%
Jun 30, 2025 -39.64%
Mar 31, 2025 -27.00%
Dec 31, 2024 -33.29%
Sep 30, 2024 19.73%
Jun 30, 2024 -14.76%
Mar 31, 2024 17.13%
Dec 31, 2023 -38.16%
Sep 30, 2023 -82.46%
Jun 30, 2023 -73.49%
Mar 31, 2023 -112.02%
Dec 31, 2022 -71.57%
Sep 30, 2022 -58.67%
Jun 30, 2022 -55.23%
Mar 31, 2022 -51.23%
Dec 31, 2021 -47.85%
Sep 30, 2021 -48.44%
API Access

Palvella Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PVLA&period=max&api_key=YOUR_API_KEY